Session date: 
08/10/2023 - 12:00pm to 1:00pm

PRESENTATION TITLE
From patients to disease modeling: Defining epithelial stem cell defects and therapeutic targets in fibrotic lung disease.

Learning objectives
Upon completion of this activity, participants should be able to:

  1. Application of single cell transcriptomics of patient-derived samples to define cell types of the normal and fibrotic lung
  2. Define cellular senescence and the contribution of senescent alveolar epithelial cells to initiation and progression of pulmonary fibrosis.

  3. Application of lineage tracing and cell type-specific conditional loss-of-function models to reveal mechanisms of lung tissue remodeling
  4. Define roles for innate immune activation in epithelial remodeling that accompanies lung disease


ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Barry R. Stripp, Ph.D.
Support location: 
Arizona

Please login or register to take this course.
Support location: 
Arizona